About this trial
To confirm the effect of Susu Xiaoer Zhike granules in treating cough caused by common cold (wind-cold cough Syndromes) in children aged 6\~13 years, shortening the course of disease and improving symptoms.
Eligibility criteria
Qualifiers
It met the diagnostic criteria for common cold, and the severity VAS score of day or night cough was ≥40 mm ,the cough symptom score was ≥2 points;
Conforming to the standard of wind-cold cough differentiation;
Age 6-13 years old (6 years old ≤ age < 14 years old);
Duration of cough ≤48 hours;
Disqualifiers
accompanied by pharyngeal swelling pain, heat image is obvious;
White blood cell count, neutrophils absolute value, C-reactive protein, all exceeded the upper limit of 1.2 times the reference value, and the researchers considered the bacterial infection;
there have been complications (bacterial otitis media, sinusitis, suppurative tonsillitis, bronchitis, bronchopneumonia);
Patients with acute bronchitis and pneumonia cured less than 8 weeks;
Trial design
Treatments tested in this trial
- Susu Xiao'er Zhike Granules
- Extremely-low dose Susu Xiao'er Zhike Granules